Table 5.
Clusters of references cooccurring in the top 100 cited papers on CFS.
| Cluster | Size | Year | LLR |
|---|---|---|---|
| 0 | 30 | 2006 | Primary care; impact; endometriosis; community; endocrine |
| 1 | 27 | 2004 | Infectious retrovirus; corticotropin releasing hormone; xmrv; hypothalamic pituitary; prostate cancer |
| 2 | 26 | 2002 | Randomized controlled trial; double blind; cognitive behavior therapy; graded exercise; placebo controlled trial |
| 3 | 26 | 2010 | Gene expression; diagnosis; chronic fatigue syndrome; myalgic encephalomyelitis; neutrophils |
| 4 | 26 | 2005 | Chronic fatigue; oxidative stress; muscle pain thresholds; neurodegenerationabuse |
| 5 | 25 | 2006 | Neural plasticityvolumetric mrivoxel-based morphometry; gray matter increase; cognitive behavioral therapy |
| 6 | 25 | 2007 | Chronic pain; fibromyalgia; pain; spatial summation; cortisol |
| 7 | 22 | 2010 | Vip; t cells; myalgic encephalomyelitis (me); vasoactive intestinal peptide; intestinal microbiota |
| 8 | 14 | 2012 | Metabolomics; systemic review; cell danger response; me; covid-19 |
| 9 | 13 | 2005 | Treatment outcome; symptoms; people; validity; fatigue syndrome |
CFS = chronic fatigue syndrome.